What I heard yesterday in the Conference call was revenue this year from HIV and COVID-19. COVID-19 is the quick revenue in 4 or so months after completion of the trial. But they haven’t given up on revenue sooner with an EUA still possible somewhere or so it was said.
When Nader talked about HIV. We know it takes 6-7 months minimum for a acceptance of BLA and receiving a PUDFA final date. For Nader to say revenue this year for HIV. We would have to file pretty soon you would think. An announcement of filing will include a simultaneous filing of 4 regulatory agencies with one push of the send button. That’s what Dr. Mahboob Rahman said he would do. All 4 regulatory agencies at the same time a few months ago he stated that.
Then other revenue is possible from a Cancer BTD mentioned once again only this time not for MTNBC but for the basket trial including MTNBC and all the 23 indications of solid tumor cancers. Saying not only will we be a COVID-19 drug but will eventually be a oncology company. When that was stated it was Dr. Kelly that stated we will be a oncology company and Dr Rahman adamantly agreed that the labs were showing that. My hope is Covid-19 will fund our BLA’S going foreword.
So the stock drops back to where we were almost pre-covid but not quite. We are still in that game and trial and time will prove what we need for covid. With a changed primary end point we have already achieved. Covid looks like a slam dunk.
HIV is looking good with Dr. Rahman in control of that BLA. So happy he is aboard and driving that indication and more hopefully in his control. There is nothing like experience and he has it.
I am down tens of thousands of dollars but the big picture is still there and I still believe. I haven’t and won’t sell a share. I am not looking to be pessimistic in our chances. I just realize that time is not now but could be soon. Not likely though. Before years end do we see revenue? I think so... that my assessment and you can believe what you want to believe. I choose to believe in the science.
You can argue that Nader won’t get us there. But at this point I am leaning on Dr. Rahman for his experience to get us over the finish line on multiple fronts and for him quite possibly to be not only our go to guy... but our future!
When Nader talked about HIV. We know it takes 6-7 months minimum for a acceptance of BLA and receiving a PUDFA final date. For Nader to say revenue this year for HIV. We would have to file pretty soon you would think. An announcement of filing will include a simultaneous filing of 4 regulatory agencies with one push of the send button. That’s what Dr. Mahboob Rahman said he would do. All 4 regulatory agencies at the same time a few months ago he stated that.
Then other revenue is possible from a Cancer BTD mentioned once again only this time not for MTNBC but for the basket trial including MTNBC and all the 23 indications of solid tumor cancers. Saying not only will we be a COVID-19 drug but will eventually be a oncology company. When that was stated it was Dr. Kelly that stated we will be a oncology company and Dr Rahman adamantly agreed that the labs were showing that. My hope is Covid-19 will fund our BLA’S going foreword.
So the stock drops back to where we were almost pre-covid but not quite. We are still in that game and trial and time will prove what we need for covid. With a changed primary end point we have already achieved. Covid looks like a slam dunk.
HIV is looking good with Dr. Rahman in control of that BLA. So happy he is aboard and driving that indication and more hopefully in his control. There is nothing like experience and he has it.
I am down tens of thousands of dollars but the big picture is still there and I still believe. I haven’t and won’t sell a share. I am not looking to be pessimistic in our chances. I just realize that time is not now but could be soon. Not likely though. Before years end do we see revenue? I think so... that my assessment and you can believe what you want to believe. I choose to believe in the science.
You can argue that Nader won’t get us there. But at this point I am leaning on Dr. Rahman for his experience to get us over the finish line on multiple fronts and for him quite possibly to be not only our go to guy... but our future!
3
